Prenetics Global Limited (NASDAQ:PRENW) Short Interest Update

Prenetics Global Limited (NASDAQ:PRENW) was the target of a large decline in short interest in July. As of July 31st, there was short interest totaling 27,675 shares, a decline of 96.5% from the July 15th total of 787,526 shares. Based on an average trading volume of 29,679 shares, the short-interest ratio is currently 0.9 days.

Prenetics Global Trading Down 4.8%

Shares of NASDAQ PRENW traded down $0.00 during mid-day trading on Tuesday, reaching $0.01. The company had a trading volume of 11,420 shares, compared to its average volume of 39,161. Prenetics Global has a twelve month low of $0.01 and a twelve month high of $0.04. The stock’s 50 day moving average is $0.01 and its 200-day moving average is $0.02.

Prenetics Global Company Profile

Prenetics Global (NASDAQ: PRENW) is a molecular diagnostics and preventive genomics company that develops and delivers DNA-based tests and diagnostic solutions. The company’s offerings include direct-to-consumer health profiling services, clinical genetic tests, and pathogen screening assays. By combining advanced laboratory processes with digital tools, Prenetics aims to provide insights into genetic risk factors, nutrition and fitness optimization, and early disease detection.

Prenetics operates a portfolio of consumer genomics brands, including DNAFit and CircleDNA, which offer personalized reports on wellness, exercise, nutrition, and inherited health traits.